-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
January 01, 2013 - disorders 12,625 0.09%
540: Cesarean delivery 553,991 3.87%
541: Vaginal delivery w sterilization &/or D&C … 27,470 0.19%
542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,091 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 7,164 0.05%
545: Ectopic pregnancy … abortion diagnoses w/o procedure 23,907 0.17%
563: Preterm labor 22,029 0.15%
564: Abortion w/o D&C,
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
January 01, 2012 - Percent
of Total
540: Cesarean delivery 521,823 3.88%
541: Vaginal delivery w sterilization &/or D&C … 26,033 0.19%
542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,015 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 7,331 0.05%
545: Ectopic pregnancy … abortion diagnoses w/o procedure 22,592 0.17%
563: Preterm labor 23,187 0.17%
564: Abortion w/o D&C,
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
January 01, 2011 - Percent
of Total
540: Cesarean delivery 534,930 3.84%
541: Vaginal delivery w sterilization &/or D&C … 28,625 0.21%
542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,223 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 9,667 0.07%
545: Ectopic pregnancy … abortion diagnoses w/o procedure 22,748 0.16%
563: Threatened abortion 25,561 0.18%
564: Abortion w/o D&C,
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
January 01, 2010 - Percent
of Total
540: Cesarean delivery 539,914 3.88%
541: Vaginal delivery w sterilization &/or D&C … 29,710 0.21%
542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,468 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 8,021 0.06%
545: Ectopic pregnancy … abortion diagnoses w/o procedure 23,183 0.17%
563: Threatened abortion 26,513 0.19%
564: Abortion w/o D&C,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
November 01, 2012 - Citations excluded at the full-text level are listed in
Appendix C in the full report, along with the … Gisondi P, Del Giglio M, Cotena C, et al. … Gisondi P, Cotena C, Tessari G, et al. … Magliocco MA, Lozano AM, Van Saders C, et al.
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2019.pdf
January 01, 2019 - Andrews R, Kassed C, Nagamine M. … HCUP (10/212021) C-1 NRD Introduction
APPENDIX C: STATE-SPECIFIC RESTRICTIONS … Table C.1. … 18.22 18.71 2.7
4: Mycoses 10,755 27.56 28.10 2.0
5: HIV infection 7,495 26.99 27.66 2.5
6: Hepatitis … infections; including
parasitic 4,117 13.46 14.09 4.7
9: Sexually transmitted
infections (not HIV or
hepatitis
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2020.pdf
January 01, 2020 - Andrews R, Kassed C, Nagamine M. … HCUP (11/16/2022) C-1 NRD Introduction
APPENDIX C: STATE-SPECIFIC RESTRICTIONS … Table C.1. … 18.22 18.71 2.7
4: Mycoses 10,755 27.56 28.10 2.0
5: HIV infection 7,495 26.99 27.66 2.5
6: Hepatitis … infections; including
parasitic 4,117 13.46 14.09 4.7
9: Sexually transmitted
infections (not HIV or
hepatitis
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE.pdf
January 01, 2023 - A-18
Appendix C. … C-1
Quality Map .................................................................................... … C-11
Appendix D. … 1
Appendix C. … measles-mumps-rubella vaccine
NIS 2021
Children ages 19-35 months who received 3 or more doses of
hepatitis
-
hcup-us.ahrq.gov/datainnovations/ICD-10_DXCCS_Trends112817.pdf
November 28, 2017 - A complete list of results by CCS diagnosis category is available in Appendices B and C. … 293.5
4: Mycoses 2,944 2,989 2,165 1.5 –27.6
5: HIV infection 3,935 3,912 3,137 –0.6 –19.8
6: Hepatitis … mouth; excluding dental 2,381 2,557 2,711 7.4 6.0
9: Sexually transmitted infections (not HIV or
hepatitis … 15,322 10,800 2.9 –29.5
181: Other complications of pregnancy 61,837 64,687 45,383 4.6 –29.8
6: Hepatitis … 1.3
4: Mycoses 59,643 63,363 66,229 6.2 4.5
5: HIV infection 21,535 25,113 26,481 16.6 5.4
6: Hepatitis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
October 01, 2012 - ...................................................................................... 26
Appendix C. … Appendix C shows the questionnaire matrix that was sent to
the experts.
2.4 Check for qualitative … Comparison of measured GFR, serum
creatinine, cystatin C, and beta-trace protein
to predict ESRD in … Goraya N, Simoni J, Jo C, et al. … Evidence Table
Appendix C. Questionnaire Matrix
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - ...................................................................................... 19
Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux
T, et al. Scleritis: a paradoxical effect of
etanercept? … Sandborg C, Mellins ED. A new era in
the treatment of systemic juvenile idiopathic
arthritis. … C-reactive
protein and ferritin normalized
within this interval in >80%. … AE’s included
bacterial infection in 2 patients
and hepatitis in 1
Key Question 2: In children with
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - ...................................................................................... 19
Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux
T, et al. Scleritis: a paradoxical effect of
etanercept? … Sandborg C, Mellins ED. A new era in
the treatment of systemic juvenile idiopathic
arthritis. … C-reactive
protein and ferritin normalized
within this interval in >80%. … AE’s included
bacterial infection in 2 patients
and hepatitis in 1
Key Question 2: In children with
-
digital.ahrq.gov/sites/default/files/docs/publication/k08hs018341-armstrong-final-report-2014.pdf
January 01, 2014 - PubMed PMID: 25085668.
2014 Ma C, Armstrong AW. … Epub 2013 Jan 18.
2012 Armstrong AW, Schupp C, Bebo B. … Association between psoriasis and viral
infections in the United States: focusing on hepatitis B, hepatitis … C, and human
immunodeficiency virus. … Kurlinkus C, Eisen DB.
-
integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/implement-mat-for-oud/screening-and-diagnosis
January 01, 2018 - of opioid use disorder; Other relevant medical conditions (i.e., pregnancy testing, liver function, hepatitis … B and C testing, HIV testing); and Other relevant psychiatric disorders, including depression and specifically
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan18/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
May 15, 2013 - including, but not limited to: mental health disorders, sexually transmitted infection/HIV transmission, hepatitis … B or C transmission, unintended pregnancies/pregnancy complications, respiratory infections, cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions
October 20, 2016 - for adolescents)
Alcohol Use Disorders Identification Test (AUDIT), its abbreviated version (AUDIT-C) … health symptoms/disorders; alcohol-related liver problems, including fatty liver disease, alcoholic hepatitis
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-pregnancy-screening-2009
May 15, 2009 - screening for other sexually transmitted diseases in pregnancy, including gonorrhea, chlamydial infection, hepatitis … [PMID: 15306757]
Wolff T, Shelton E, Sessions C, Miller T.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
January 15, 2016 - Research Review Citation: Chinnadurai S, Snyder K, Sathe N, Fonnesbeck C, Morad A,
Likis FE, Surawicz … T, Ness G, Ficzere C, McPheeters ML. … Peer reviewer #1 Methods Fig C- Final Health Outcomes: is there a causation for
problems with thyroid … Timolol – 64% clearance
c. intralesionalTriamcinolone – 54%
d.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-abuse-screening-1996
January 01, 1996 - complications from injecting contaminated materials (e.g., human immunodeficiency virus [HIV] infection, hepatitis … Colmorgen GHC, Johnson C, Zazzarino MA, et al. … Chasnoff IJ, Griffith DR, Freier C, Murray J. … Wickizer T, Maynard C, Atherly A, et al. … Power R, Hartnoll R, Chalmers C.
-
hcup-us.ahrq.gov/toolssoftware/ccs/CCSCategoryNames_FullLabels.pdf
October 07, 2016 - 2 Septicemia (except in labor)
3 Bacterial infection; unspecified site
4 Mycoses
5 HIV infection
6 Hepatitis … Viral infection
8 Other infections; including parasitic
9 Sexually transmitted infections (not HIV or hepatitis … excision of cervix and uterus
126 Abortion (termination of pregnancy)
127 Dilatation and curettage (D&C) … specified septicemia
1.1.2.6 Unspecified septicemia
1.1.3 Sexually transmitted infections (not HIV or hepatitis … Candidiasis of the mouth (thrush)
1.2.2 Other mycoses
1.3 Viral infection
1.3.1 HIV infection [5]
1.3.2 Hepatitis